Compare INSG & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INSG | EMBC |
|---|---|---|
| Founded | 1996 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.1M | 200.5M |
| IPO Year | 2000 | 2021 |
| Metric | INSG | EMBC |
|---|---|---|
| Price | $10.52 | $3.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $15.33 | ★ $18.50 |
| AVG Volume (30 Days) | 448.1K | ★ 2.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.88% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | 0.65 | ★ 0.67 |
| Revenue | ★ $313,832,000.00 | N/A |
| Revenue This Year | $16.21 | $1.17 |
| Revenue Next Year | $13.28 | N/A |
| P/E Ratio | $15.95 | ★ $4.79 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.28 | $2.77 |
| 52 Week High | $21.90 | $15.55 |
| Indicator | INSG | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 35.08 | 26.23 |
| Support Level | $9.35 | $2.77 |
| Resistance Level | $12.61 | $3.48 |
| Average True Range (ATR) | 1.23 | 0.17 |
| MACD | -0.29 | 0.19 |
| Stochastic Oscillator | 16.10 | 22.12 |
Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.